A study of serum lipid profile in normal pregnancy and pregnancy induced hypertensive disorders: a case-control study

Blessy Prabhu Priyanka S., A. Padma Vijayasree, Devraj J. P., Santosh Kumar B., Mahesh Kumar Mummadi, Naveen Kumar Boiroju


Background: Pregnancy induced hypertensive disorders are one of the commonest complication of pregnancy which accounts for 12% of the maternal and perinatal mortality and morbidity. Dyslipidemias are associated with endothelial dysfunction that may result in proteinuria and hypertension which is a clinical hallmark of PIH. It affects both maternal health as well as fetal growth. Hence, this study was done to assess the role of altered lipid profile in the development of PIH.

Methods: A Case Control study was conducted at the Department of Biochemistry, Kurnool Medical College and Govt General Hospital, Kurnool in collaboration with its Obstetrics Dept during the period of November 2015-2017. A total of 300 pregnant women, primigravida /multigravida with singleton pregnancy, in the age group of 18‐ 35 years with >20 weeks of gestation were included in the study. Subjects were divided into gestational hypertensives, n=39 (BP ≥140/80) and preeclamptic women, n=111 (≥140/80 and proteinuria) as cases. Age matched normotensive pregnant women, n=150 (BP 120/80) were recruited as Controls. Subjects with history of multiple pregnancies, pregnancy with congenital anomalies, chronic hypertension, diabetes mellitus, cardiac/thyroid/hepatic/renal disease, dyslipidemia were excluded. Total cholesterol, TG, HDL, LDL, VLDL were performed.

Results: A comparison of these values between hypertensive and normotensive women showed a significant rise in TC, TG, LDL and VLDL. HDL-C showed a significant decrease in hypertensive women compared to normal pregnant women. LDL: HDL and TG:HDL ratios were higher in PIH group.

Conclusions: The results of this study suggests an abnormal lipid metabolism, predominantly high TG concentrations and low HDL-C, which may add to the promotion of vascular dysfunction and oxidative stress seen in PIH. This association is significant in understanding the development of hypertension during pregnancy and is useful in early diagnosis and prevention of PIH.


Dyslipidemia, Gestational HTN, Lipid Profile, PIH, Pregnancy, Pre-eclampsia

Full Text:



Von Dadelszen P, Magee LA. Pre-eclampsia: anupdate. Curr Hypertens Rep. 2014;16(8):1-14.

vonDadelszen P, Magee LA. Preventing deaths due to the hypertensive disorders of pregnancy. Best Practice Res Clin Obstetr Gynaecol. 2016;36:83-102.

Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol. 2002;186(1):66-71.

Saudan P, Brown MA, Buddle ML, Jones M. Does gestational hypertension become preeclampsia? Br J Obstet Gynaecol. 1998;105(11):1177-84.

Direkvand-Moghadam A, Khosravi A, Sayehmiri K. Predictive factors for preeclampsia in pregnant women: a unvariate and multivariate logistic regression analysis. Acta Biochim Pol. 2012;59(4):673-7.

Lawler J, Osman M, Shelton JA, Yeh J. Population based analysis of hypertensive disorders in pregnancy. Hypertens Pregnancy. 2007;26:67-76.

Ferrer RI, Sibai BM, Mulrow CD, Chiquette E, Stevens KR, Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol. 2000;96:849-60.

Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, et al. Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 2006;355:992-1005.

Robson SC. Hypertension and renal disease in pregnancy, In: Dewhurst’s Textbook of Obstetrics and Gynaecology for postgraduates, Ed. Edmonds, D.K., 6th edition, Blackwell Science Ltd.,New York. 1999:167-9.

Young BC, Levine RJ, Karumanchi SA. Pathogenesis of preeclampsia. Annu Rev Pathol. 2010;5:173-92.

Jayanta De, Ananda K, Mukhopadhyay, Pradip KS. Study of serum lipid profile in pregnancy induced hypertension. Ind J Clin Biochem. 2006;21.

Winkler K, Wetzka B, Hoffmann MM, Friedrich I, Kinner M, Manfred WB, et al. Triglyceride-rich lipoproteins are associated with hypertension in pre-eclampsia. The J Clin Endocrinol Metabol. 2003;88:1162-6.

Hubel CA. Oxidative stress in the pathogenesis of preeclampsia. Proc Soc Exp Biol Med. 1999;222:222-35.

Sahu S, Abraham R. Vedavalli R, Daniel M. Study of lipid profile, lipid peroxidation and vitamin E in pregnancy induced hypertension. Indian J Physiol Pharmacol. 2009;53(4):365-9.

Lamminpaa R. Preeclampsia complicated by advanced maternal age: a registry-based study on primiparous women in Finland. 1997-2008. BMC. Pregnancy Childbirth. 2012;12(1):47.

Yadav S, Yadav R, Saxena U. Hypertensive disorders of pregnancy and perinatal outcome. J Obset Gynecol India. 1997;17:322-30.

Bangal V, Giri P, Mahajan A. Maternal and foetal outcome in pregnancy induced hypertension: a study from rural tertiary care teaching hospital in India. Int J Biomed Res. 2011;2(12):595‐9.

Gailard R. Maternal obesity during pregnancy and cardiovascular development and disease in the offspring. European J Epidemiol. 2015:30:1141-52.

Meenakshi ST, Anjoo A, Vinita D. Advanced maternal age and obstetric outcome. J OBG GYN India. 2007;57(4):320-3.

Kumar SG. Determinants of pre-eclampsia: a case-control study in a district hospital in South India. Indian J Community Med. 2010;35(4):502-5.

Mostello D, Kallogjeri D, Tungsiripat R, Leet T. Recurrence of preeclampsia: effects of gestational age at delivery of the first pregnancy, body mass index, paternity, and interval between births. Am J Obstet Gynecol. 2008;199:55e1-e7.

Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol. 2002:100:369-77.

Karanpreet Bhutani K, Vij C, Bedi GK, Kaur M, Singh U, et al. Predictive and prognostic value of thyroid profile and lipid profile in pregnancy induced hypertension. J Preg Child Health. doi:10.4172/2376- 127X.1000144.

Anjum R, Zahra N, Rehman K, Alam R, Parveen A. Comparative analysis of serum lipid profile between normotensive and hypertensive Pakistani pregnant women. J Mol Genet Med. 2013;7:64.

Dong X. Proteinuria in preeclampsia;evaluation and management;pregnancy. Hypertens. 2017;8:60.

Kim MJ. Is massive proteinuria associated with maternal and fetal morbidities in preeclampsia. Obstet Gynae Sci. 2017;60(3):260.

Diagnosis and Management of preeclampsia and Eclampsia. ACOG practice Bulltein. 2002:33.

Breetha V. Hypertriglyceridemia in pregnancy induced hypertension. JMSCR. 2016;4(11).

Sattar N, Bendomir A, Berry C, Shepherd J, Greer IA, Packard CJ. Lipoprotein subfraction concentrations in pre-eclampsia: Pathogenic parallels to atherosclerosis. Obstet Gynecol. 1997;89:403-8.

Kokia E, Barkai G, Reichman B, Segal P, Goldman B, Mashiach S. Maternal serum lipid profile in pregnancies complicated by hypertensive disorders. J Perinat Med. 1990;18:473-8.

Ramsay JE, Jamieson N, Greer IA, Sattar N. Paradoxical elevation in adiponectin concentrations in women with preeclampsia. Hypertension. 2003;42:891-4.

Kaloti AS. Study of lipid profile trends in women of pregnancy induced hypertension cases in a rural setup. J Evol Med Dent Sci. 2013;2(13).

Shivanagappa. Lipid profile in pregnancy hypertension. Int J Scient Study. 2015;3(7).

Ekhator CN, Ebomoyi MI. Blood glucose and serum lipid profiles during pregnancy. Afr J Diabetes Med. 2012;20:16-9.

Bellamy L, Casas JP, Hingorani AD. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta- analysis. BMJ. 2007;335(7627):974.